{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T01:16:41Z","timestamp":1760404601165},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,3,11]],"date-time":"2015-03-11T00:00:00Z","timestamp":1426032000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00280-015-2721-z","type":"journal-article","created":{"date-parts":[[2015,3,10]],"date-time":"2015-03-10T12:02:30Z","timestamp":1425988950000},"page":"969-974","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Levels of sirolimus in saliva and blood following oral topical sustained-release varnish delivery system application"],"prefix":"10.1007","volume":"75","author":[{"given":"Zakhar","family":"Nudelman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mordechai","family":"Findler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinorah","family":"Barasch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Nemirovski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Pikovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Kirmayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maamoun","family":"Basheer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Silvio","family":"Gutkind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakefet","family":"Czerninski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,11]]},"reference":[{"key":"2721_CR1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fonc.2014.00064","volume":"4","author":"C Porta","year":"2014","unstructured":"Porta C, Paglino C, Mosca A (2014) Targeting PI3K\/Akt\/mTOR signaling in cancer. Front Oncol 4:64. doi: 10.3389\/fonc.2014.00064","journal-title":"Front Oncol"},{"issue":"9","key":"2721_CR2","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/ijc.28112","volume":"133","author":"P Bose","year":"2013","unstructured":"Bose P, Brockton NT, Dort JC (2013) Head and neck cancer: from anatomy to biology. Int J Cancer 133(9):2013\u20132023. doi: 10.1002\/ijc.28112","journal-title":"Int J Cancer"},{"issue":"1","key":"2721_CR3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1158\/1940-6207.CAPR-08-0147","volume":"2","author":"R Czerninski","year":"2009","unstructured":"Czerninski R, Amornphimoltham P, Patel V, Molinolo AA, Gutkind JS (2009) Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model. Cancer Prev Res 2(1):27\u201336. doi: 10.1158\/1940-6207.CAPR-08-0147","journal-title":"Cancer Prev Res"},{"issue":"2","key":"2721_CR4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrd4204","volume":"13","author":"DA Fruman","year":"2014","unstructured":"Fruman DA, Rommel C (2014) PI3K and cancer: lessons, challenges and opportunities. Nat Rev Drug Discov 13(2):140\u2013156. doi: 10.1038\/nrd4204","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"2721_CR5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1601-0825.2009.01563.x","volume":"15","author":"C Scully","year":"2009","unstructured":"Scully C, Bagan J (2009) Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications. Oral Dis 15(6):388\u2013399. doi: 10.1111\/j.1601-0825.2009.01563.x","journal-title":"Oral Dis"},{"key":"2721_CR6","unstructured":"ClinicalTrails.gov. Rapamycin therapy in head and neck squamous cell carcinoma. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01195922?term=%22sirolimus%22+And+%22head+and+neck%22&rank=2 . Accessed Nov 2014"},{"issue":"10","key":"2721_CR7","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.oraloncology.2011.08.009","volume":"47","author":"MA Oliveira de","year":"2011","unstructured":"de Oliveira MA, Martins EMF, Wang Q, Sonis S, Demetri G, George S, Butrynski J, Treister NS (2011) Clinical presentation and management of mTOR inhibitor-associated stomatitis. Oral Oncol 47(10):998\u20131003. doi: 10.1016\/j.oraloncology.2011.08.009","journal-title":"Oral Oncol"},{"issue":"4","key":"2721_CR8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1023\/A:1015898717936","volume":"7","author":"M Friedman","year":"1990","unstructured":"Friedman M, Steinberg D (1990) Sustained-release delivery systems for treatment of dental diseases. Pharm Res 7(4):313\u2013317","journal-title":"Pharm Res"},{"issue":"2","key":"2721_CR9","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/jbm.b.30266","volume":"77","author":"D Steinberg","year":"2006","unstructured":"Steinberg D, Tal T, Friedman M (2006) Sustained-release delivery systems of triclosan for treatment of Streptococcus mutans biofilm. J Biomed Mater Res B Appl Biomater 77(2):282\u2013286","journal-title":"J Biomed Mater Res B Appl Biomater"},{"issue":"1","key":"2721_CR10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4103\/2229-5178.105488","volume":"4","author":"B Madke","year":"2013","unstructured":"Madke B (2013) Topical rapamycin (sirolimus) for facial angiofibromas. Indian Dermatol Online J 4(1):54\u201357. doi: 10.4103\/2229-5178.105488","journal-title":"Indian Dermatol Online J"},{"issue":"9","key":"2721_CR11","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1600-0625.2010.01102.x","volume":"19","author":"M Kremer","year":"2010","unstructured":"Kremer M, Sliva K, Klemke CD, Schnierle BS (2010) Cutaneous T-cell lymphoma cells are sensitive to rapamycin. Exp Dermatol 19(9):800\u2013805. doi: 10.1111\/j.1600-0625.2010.01102.x","journal-title":"Exp Dermatol"},{"issue":"1","key":"2721_CR12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1869-5760-3-32","volume":"3","author":"QD Nguyen","year":"2013","unstructured":"Nguyen QD, Ibrahim MA, Watters A, Bittencourt M, Yohannan J, Sepah YJ, Dunn JP, Naor J, Shams N, Shaikh O, Leder HA, Do DV (2013) Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE Study. J Ophthalmic Inflamm Infect 3(1):32. doi: 10.1186\/1869-5760-3-32","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"1","key":"2721_CR13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000172830","volume":"218","author":"A Soria","year":"2009","unstructured":"Soria A, Agbo-Godeau S, Taieb A, Frances C (2009) Treatment of refractory oral erosive lichen planus with topical rapamycin: 7 cases. Dermatology 218(1):22\u201325. doi: 10.1159\/000172830","journal-title":"Dermatology"},{"issue":"8","key":"2721_CR14","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/jcp.24351","volume":"228","author":"A Alayev","year":"2013","unstructured":"Alayev A, Holz MK (2013) mTOR signaling for biological control and cancer. J Cell Physiol 228(8):1658\u20131664. doi: 10.1002\/jcp.24351","journal-title":"J Cell Physiol"},{"issue":"1","key":"2721_CR15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11864-011-0180-2","volume":"13","author":"SA Nguyen","year":"2012","unstructured":"Nguyen SA, Walker D, Gillespie MB, Gutkind JS, Day TA (2012) mTOR inhibitors and its role in the treatment of head and neck squamous cell carcinoma. Curr Treat Options Oncol 13(1):71\u201381. doi: 10.1007\/s11864-011-0180-2","journal-title":"Curr Treat Options Oncol"},{"issue":"2","key":"2721_CR16","first-page":"107","volume":"64","author":"N Pallet","year":"2006","unstructured":"Pallet N, Beaune P, Legendre C, Anglicheau D (2006) Rapamycine and mTOR inhibitors: from bench to bedside. Ann Biol Clin 64(2):107\u2013115","journal-title":"Ann Biol Clin"},{"key":"2721_CR17","doi-asserted-by":"crossref","unstructured":"Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A (2006) Interventions for treating oral leukoplakia. The Cochrane database of systematic reviews (4):CD001829. doi: 10.1002\/14651858.CD001829.pub3","DOI":"10.1002\/14651858.CD001829.pub3"},{"issue":"7","key":"2721_CR18","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/jnci\/djj091","volume":"98","author":"FR Khuri","year":"2006","unstructured":"Khuri FR, Lee JJ, Lippman SM, Kim ES, Cooper JS, Benner SE, Winn R, Pajak TF, Williams B, Shenouda G, Hodson I, Fu K, Shin DM, Vokes EE, Feng L, Goepfert H, Hong WK (2006) Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst 98(7):441\u2013450. doi: 10.1093\/jnci\/djj091","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"2721_CR19","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1158\/1078-0432.CCR-05-2636","volume":"12","author":"SM Lippman","year":"2006","unstructured":"Lippman SM, Lee JJ, Martin JW, El-Naggar AK, Xu X, Shin DM, Thomas M, Mao L, Fritsche HA Jr, Zhou X, Papadimitrakopoulou V, Khuri FR, Tran H, Clayman GL, Hittelman WN, Hong WK, Lotan R (2006) Fenretinide activity in retinoid-resistant oral leukoplakia. Clin Cancer Res 12(10):3109\u20133114. doi: 10.1158\/1078-0432.CCR-05-2636","journal-title":"Clin Cancer Res"},{"key":"2721_CR20","author":"Z Nudelman","year":"2014","unstructured":"Nudelman Z, Friedman M, Barasch D, Nemirovski A, Findler M, Pikovsky A, Gutkind J, Czerninski R (2014) Levels of sirolimus in saliva and blood following mouthwash application. Oral Dis. doi: 10.1111\/odi.12229","journal-title":"Oral Dis"},{"issue":"10","key":"2721_CR21","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1515\/CCLM.2010.288","volume":"48","author":"C Courtais","year":"2010","unstructured":"Courtais C, Dupuy AM, Sophie Bargnoux A, Pageaux GP, Fegueux N, Mourad G, Cristol JP (2010) Evaluation of two sirolimus assays using the ARCHITECT-i1000((R)) CMIA or RxL((R)) ACMIA methods in comparison with the IMx((R)) MEIA method. Clin Chem Lab Med 48(10):1523\u20131525. doi: 10.1515\/CCLM.2010.288","journal-title":"Clin Chem Lab Med"},{"key":"2721_CR22","unstructured":"ClinicalTrails.gov. Rapalogs in clinical trials for the treatment of oral squamous cell carcinoma. https:\/\/clinicaltrials.gov\/ct2\/results?term=%22Sirolimus%22+and+%22squamous+cell+carcinoma+%22&Search=Search . Accessed Nov 2014"},{"issue":"3","key":"2721_CR23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.stem.2012.06.007","volume":"11","author":"R Iglesias-Bartolome","year":"2012","unstructured":"Iglesias-Bartolome R, Patel V, Cotrim A, Leelahavanichkul K, Molinolo AA, Mitchell JB, Gutkind JS (2012) mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis. Cell Stem Cell 11(3):401\u2013414. doi: 10.1016\/j.stem.2012.06.007","journal-title":"Cell Stem Cell"},{"issue":"6","key":"2721_CR24","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1593\/neo.13432","volume":"15","author":"JD Coppock","year":"2013","unstructured":"Coppock JD, Wieking BG, Molinolo AA, Gutkind JS, Miskimins WK, Lee JH (2013) Improved clearance during treatment of HPV-positive head and neck cancer through mTOR inhibition. Neoplasia 15(6):620\u2013630","journal-title":"Neoplasia"},{"issue":"3","key":"2721_CR25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1067\/mod.2003.19","volume":"123","author":"N Beyth","year":"2003","unstructured":"Beyth N, Redlich M, Harari D, Friedman M, Steinberg D (2003) Effect of sustained-release chlorhexidine varnish on Streptococcus mutans and Actinomyces viscosus in orthodontic patients. Am J Orthod Dentofac Orthop 123(3):345\u2013348. doi: 10.1067\/mod.2003.19","journal-title":"Am J Orthod Dentofac Orthop"},{"issue":"6","key":"2721_CR26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1159\/000066539","volume":"36","author":"D Steinberg","year":"2002","unstructured":"Steinberg D, Rozen R, Klausner EA, Zachs B, Friedman M (2002) Formulation, development and characterization of sustained release varnishes containing amine and stannous fluorides. Caries Res 36(6):411\u2013416. doi: 10.1159\/000066539","journal-title":"Caries Res"},{"issue":"1","key":"2721_CR27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00784-009-0275-3","volume":"14","author":"R Czerninski","year":"2010","unstructured":"Czerninski R, Sivan S, Steinberg D, Gati I, Kagan L, Friedman M (2010) A novel sustained-release clotrimazole varnish for local treatment of oral candidiasis. Clin Oral Investig 14(1):71\u201378. doi: 10.1007\/s00784-009-0275-3","journal-title":"Clin Oral Investig"},{"issue":"2","key":"2721_CR28","first-page":"661","volume":"33","author":"Z Nudelman","year":"2013","unstructured":"Nudelman Z, Keshet N, Elhalal MD, Friedman M, Czerninski R (2013) Levels of sirolimus in saliva vs. blood\u2014the rationale of topical oral use for oral malignancy. Anticancer Res 33(2):661\u2013663","journal-title":"Anticancer Res"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-015-2721-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-015-2721-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-015-2721-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T10:11:46Z","timestamp":1559038306000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-015-2721-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,11]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["2721"],"URL":"https:\/\/doi.org\/10.1007\/s00280-015-2721-z","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,11]]}}}